Self‐Amplifying AIE Probe for HClO‐Activatable Imaging and Antioxidative/Anti‐Inflammatory Therapy of Thoracic Aortic Dissection
Angewandte Chemie International Edition · 2026
DOI: 10.1002/anie.3622603 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2026. Verfasst von Yanzi Xu und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, Engineering Research Center of Energy Storage Materials and Devices, Ministry of Education, Xi'an Jiaotong University, Xi'an, P.…. Hauptthemen laut MEDLINE: Hypochlorous Acid, Antioxidants, Fluorescent Dyes, Anti-Inflammatory Agents. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Noncommunicable Chronic Diseases-National Science and Technology Major Project.
Abstract (Originalsprache)
Thoracic aortic dissection (TAD) is a highly lethal cardiovascular disease, yet its accurate diagnosis and effective treatment remain challenging due to poor imaging contrast and insufficient specificity. Leveraging the overexpressed reactive oxygen species (ROS) in TAD, we reported a hypochlorous acid (HClO)‐activatable molecular probe DT‐PZ. It enables two‐stage self‐amplifying fluorescence imaging (chemical activation and then physical aggregation) and light‐independent therapy on a single chemical entity. The probe initially exhibits quenched fluorescence via photoinduced electron transfer (PET). Two pathways can turn on the fluorescence via chemical activation: (1) oxidation by HClO blocks PET and turns on the emission; (2) photo‐triggered radicals generation of HClO (via chloride ions or myeloperoxidase) to activate neighboring probes, creating self‐amplifying fluorescence. Upon accumulation at the lesion site, the physical aggregation caused by the aggregation‐induced emission effect further amplifies the fluorescence signals. This two‐stage fluorescence amplification mechanism enables TAD visualization within 2 min in vivo. For therapy, the phenothiazine scavenges excess ROS during non‐illuminated periods, down‐regulates the NF‐κB/P65 signal pathway, and up‐regulates eNOS and P‐Akt expressions, protecting endothelial homeostasis and then improving murine survival from 50% to 90%. Collectively, DT‐PZ synergizes self‐amplifying fluorescence imaging with light‐independent antioxidation/anti‐inflammatory therapy, holding great promise for managing deep‐seated cardiovascular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry, Engineering Research Center of Energy Storage Materials and Devices, Ministry of Education, Xi'an Jiaotong University, Xi'an, P. R. China.
- Department of Cardiovascular Surgery, Xijing Hospital of Air Force Military, Xi'an, P. R. China.
- Department of Chemistry and Department of Chemical and Biological Engineering, The Hong Kong Branch of Chinese National Engineering Research Center for Tissue Restoration and Reconstruction, Division of Life Science and…
- MOE Frontiers Science Center for Precision Oncology, Faculty of Health Sciences, University of Macau, Macao, P. R. China.
- Instrumental Analysis Center of Xi'an Jiaotong University, Xi'an, P. R. China.
- Guangdong Basic Research Center of Excellence for Aggregate Science, School of Science and Engineering, The Chinese University of Hong Kong (Shenzhen), Shenzhen, Guangdong, P. R. China.
ORCID-Profile: Yanzi Xu, Ryan T K Kwok, Changhuo Xu, Lingjie Meng, Weixun Duan, Dongfeng Dang, Ben Zhong Tang
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- Innovation and Technology Commission of Hong Kong
- Key Program of Shaanxi Provincial Natural Science Basic Research Plan
- Science and Technology Innovation Team Projects of Shaanxi Province
- "Young Talent Support Plan" of Xi'an Jiaotong University
- Tang Scholar of Xi'an Jiaotong University
Zitieren
APA
Xu, Y., Luo, Y., Shen, J., Deng, Z., Gao, A., Yang, S., Lam, J. W. Y., Kwok, R. T. K., Xu, C., Meng, L., Duan, W., Dang, D., & Tang, B. Z. (2026). Self‐Amplifying AIE Probe for HClO‐Activatable Imaging and Antioxidative/Anti‐Inflammatory Therapy of Thoracic Aortic Dissection. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.3622603
Vancouver
Xu Y, Luo Y, Shen J, Deng Z, Gao A, Yang S, et al. Self‐Amplifying AIE Probe for HClO‐Activatable Imaging and Antioxidative/Anti‐Inflammatory Therapy of Thoracic Aortic Dissection. Angewandte Chemie International Edition. 2026. doi:10.1002/anie.3622603
BibTeX
@article{Xu2026,
author = {Xu, Yanzi and Luo, Yunpeng and Shen, Jiale and Deng, Zihao and Gao, Anran and Yang, Shengyi and Lam, Jacky W Y and Kwok, Ryan T K and Xu, Changhuo and Meng, Lingjie and Duan, Weixun and Dang, Dongfeng and Tang, Ben Zhong},
title = {Self‐Amplifying AIE Probe for HClO‐Activatable Imaging and Antioxidative/Anti‐Inflammatory Therapy of Thoracic Aortic Dissection},
journal = {Angewandte Chemie International Edition},
year = {2026},
doi = {10.1002/anie.3622603}
}
EUVIMED